Press release
United States Psychedelic Drugs Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Cybin Corp, Pfizer Inc., Jazz Pharmaceuticals Inc., Atai Life Sciences N.V., PharmaTher Holdings
Psychedelic Drugs Market - DataM Intelligence
DataM Intelligence has published a new research report on "Psychedelic Drugs Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/psychedelic-drugs-market?sg
Key Players: Compass Pathways, MindMed, Hikma Pharmaceuticals, Celon Pharmaceuticals, Cybin Corp, Pfizer Inc., Jazz Pharmaceuticals Inc., Atai Life Sciences N.V., PharmaTher Holdings Ltd., and GH Research PLC.
Industry Latest News 2025:
✅ 03 Feb 2025 - GH Research (GH001) - GH Research announced its Phase-2b trial of GH001 (an inhaled mebufotenin product) met its primary endpoint with a large placebo-adjusted MADRS improvement.
✅ 28 Jan 2025 - atai Life Sciences / Beckley Psytech (Phase 2a) - atai reported positive topline results from Beckley Psytech's Phase-2a/open-label study of BPL-003 (intranasal mebufotenin / 5-MeO-DMT benzoate), marking an early clinical win in 2025.
✅ 22 Apr 2025 - Compass Pathways (COMP360) - Compass announced dosing complete for all participants in Part A of its Phase-3 COMP005 trial of COMP360 (synthetic psilocybin) and said topline results were expected in late June.
✅ 23 Jun 2025 - Compass Pathways (COMP360) - Compass publicly announced that Part A of the Phase-3 COMP005 trial met its primary 6-week endpoint (COMP360), a major mid-2025 clinical milestone for psilocybin therapy.
✅ 01 Jul 2025 - atai / Beckley (BPL-003 Phase-2b topline) - Beckley/atai announced positive topline Phase-2b results for BPL-003 (intranasal 5-MeO-DMT benzoate) in treatment-resistant depression (statistically significant reductions on MADRS and secondary endpoints).
✅ 08 May 2025 - Otsuka + Keio University (Japan) - Otsuka Pharmaceutical signed a basic research / joint agreement with Keio University to build infrastructure for the social implementation and responsible clinical development of psychedelics in Japan (research framework, ethics, training). (This signals Japan's cautious, infrastructure-first approach in 2025.)
✅ 03 Jun - 23 Jul 2025 (updates) - GH Research follow-ups - after the Feb result, GH Research published Q1/Q2 updates and outlined plans for a global pivotal programme for GH001, accelerating plans toward late-stage development across 2025.
✅ 25 Aug 2025 - AbbVie / Gilgamesh (M&A - deal announced in 2025) - AbbVie announced a deal to acquire Gilgamesh's bretisilocin programme (psychedelic-like 5-HT2A agonist) in a transaction reported at up to ~$1.2 billion (deal announced 25-Aug-2025).
Growth Forecast Projected:
The Global Psychedelic Drugs Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Psychedelic Drugs Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports): https://www.datamintelligence.com/buy-now-page?report=psychedelic-drugs-market?sg
Key Segments:
By Drug Type (Lysergic Acid Diethylamide, Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others )
By Application (Treatment-Resistant Depression, Post-Traumatic Stress Disorder, Narcolepsy, Panic Disorders, Others)
By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Psychedelic Drugs producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Psychedelic Drugs revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/psychedelic-drugs-market?sg
FAQ's
Q1: What is the current size of the Psychedelic Drugs Market?
A: The Psychedelic Drugs Market stood at US$ 3.31 Billion in 2024 and is set to experience remarkable growth, reaching US$ 9.20 Billion by 2033
Q2: How fast is the Psychedelic Drugs Market growing?
A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 12.1% from 2025-2033
Q3: Which regions are dominating the Psychedelic Drugs Market and which are fastest-growing?
A: North America dominated the global psychedelic drugs market with the highest share of 44.8% in 2024
Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/psychedelic-drugs-market?sg
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?sg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Psychedelic Drugs Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Cybin Corp, Pfizer Inc., Jazz Pharmaceuticals Inc., Atai Life Sciences N.V., PharmaTher Holdings here
News-ID: 4252958 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
E-Waste Management Industry Sector in 2025 | Recycling Technologies & Circular E …
DataM Intelligence unveils its latest report on the "E-Waste Management Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming…
United States Calcium Carbonate Market 2025: Industry Developments, Future Growt …
Calcium Carbonate Market is expected to grow at a CAGR of 4.19% during the forecast period 2024-2031.
DataM Intelligence has published a new research report on "Calcium Carbonate Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market…
Japan Therapeutic Plasma Exchange Market Size, Share, and Growth Outlook | Major …
Tokyo-Japan:- Japan's therapeutic plasma exchange market size in 2025 is around USD 2.8 billion, growing at an estimated CAGR of about 9.1%. the market is growing due to Japan's ageing population and increasing prevalence of chronic, autoimmune and hematological disorders create greater demand for advanced therapies like therapeutic plasma exchange. As per the DataM Intelligence Report.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email…
Japan Endoscope Reprocessing Market Size & Forecast 2025 - 2030: Patient Safety …
Tokyo, Japan DataM Intelligence: The Japan Endoscope Reprocessing Market is valued at USD 113.2 million in 2023. It is expected to grow to USD 231.2 million by 2030, with a CAGR of 10.7%.
This growth comes from more endoscopy procedures, strict regulatory standards, greater awareness of infection control, and the use of automated endoscope reprocessors. Japan's aging population, emphasis on patient safety, and government efforts to improve healthcare infrastructure make it…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
